Document is current
Any future updates will be listed below
-
Authors
Vicenzi, Silvia
Gao, Fangyuan
Côté, Parker
Hartman, Joshua D.
Avsharian, Lara C.
Vora, Ashni A.
Rowe, R. Grant
Li, Hojun
Skowronska-Krawczyk, Dorota
Crews, Leslie A. https://orcid.org/0000-0003-0704-0067
-
Funding
Funding for this research was provided by:
California Institute of Regenerative Medicine (EDUC4-12804)
National Cancer Institute (R37CA252040)
National Cancer Institute (P30CA023100)
National Eye Institute (U01EY034594)
National Eye Institute (P30EY034070)
NIH/NIDDK (K08DK123414)
Leukemia and Lymphoma Society
- License Information
-
More Information
Article History
Received: 17 January 2025
Accepted: 28 February 2025
First Online: 15 April 2025
Declarations
:
: DS-K is a scientific advisor of Visgenx, Inc. All other authors have no competing interests to disclose.
: All studies were performed in accordance with institutional guidelines, informed consent (where relevant for human subjects) and approval processes. Animal procedures were performed in accordance with the UC Irvine Animal Care and Use Committee guidelines and IACUC protocols (#AUP-23-064). All authors have reviewed the manuscript and agree with its submission for publication.
